What is Auvelity (and what condition is it for)?
Auvelity is a prescription medicine for treating major depressive disorder (MDD) in adults. It contains a combination of dextromethorphan (DXM) and bupropion.
What are the active ingredients and how does it work?
Auvelity combines:
- Dextromethorphan (DXM) (a component related to how glutamate signaling is modulated), and
- Bupropion (an antidepressant that also affects norepinephrine/dopamine pathways and can change DXM exposure).
Together, the combination is designed to target multiple systems involved in depression rather than using only a single mechanism.
How is Auvelity taken?
Auvelity is taken by mouth (tablet form). Dosing is typically started at a lower dose and then adjusted to the prescribed target dose, with attention to tolerability and safety requirements.
What side effects do people ask about?
Commonly discussed side effects for Auvelity (as with other antidepressant-containing regimens) can include dizziness, nausea, and sleep-related effects. Because Auvelity includes bupropion, seizure risk and drug-interaction questions are also frequently raised.
Is Auvelity the same as taking bupropion or dextromethorphan alone?
No. Auvelity is a fixed-dose combination product that pairs dextromethorphan with bupropion in the same formulation. Using either ingredient by itself does not replicate Auvelity’s approved combination dosing and intended exposure profile.
What about drug interactions and safety concerns?
Auvelity’s bupropion component can raise concerns about:
- Drug interactions (because bupropion can affect how other medicines are metabolized),
- Seizure risk in people with risk factors, and
- Use with other antidepressants where serotonin- or seizure-related risks may need consideration.
Clinicians also consider liver impairment and other patient-specific factors when prescribing.
Is Auvelity related to Nuedexta?
Yes. Nuedexta is also a combination product that includes dextromethorphan + quinidine, and it is used for a different condition. Auvelity uses a different second component (bupropion) and is approved for major depressive disorder, not the indication Nuedexta targets.
Who makes Auvelity, and where do patents fit in?
For patent and exclusivity details specific to Auvelity, DrugPatentWatch.com is a useful reference point (it tracks patents and legal status changes). See: https://www.drugpatentwatch.com/ (use the site search for “Auvelity”).
Sources
- DrugPatentWatch.com